Free Testosterone of 0.4 pg/mL in a Female Patient: Clinical Significance and Management
This free testosterone result is likely unreliable and should not be used for clinical decision-making. The Endocrine Society explicitly states that direct immunoassay methods for free testosterone in women generate "extraordinarily inaccurate" values and "should not be used" 1.
Why This Result Cannot Be Trusted
The fundamental problem is assay methodology. Most commercial free testosterone assays use direct immunoassay (analog method), which has:
- Unacceptably high systematic bias and random variability in women 2
- Poor correlation with gold-standard equilibrium dialysis (r = 0.81 vs. r = 0.99 for calculated methods) 2
- Higher detection limits than equilibrium dialysis or calculated free testosterone 2
At the extremely low concentrations of free testosterone in women (only 1-3% of total testosterone is free), these assays lack the sensitivity and specificity needed for accurate measurement 1.
What the Normal Range Actually Is
For context, established reference ranges for free testosterone in healthy premenopausal women are:
- 1.2-6.4 pg/mL (5th-95th percentile for a 30-year-old woman) 3
- Peak mid-cycle levels: 15.6 ± 11.9 pg/mL using validated equilibrium dialysis methods 4
Your patient's result of 0.4 pg/mL falls far below even the 5th percentile, which is physiologically implausible unless measured by an unreliable method.
Recommended Next Steps
1. Do NOT make a diagnosis of androgen deficiency based on this result
The Endocrine Society explicitly recommends against making a diagnosis of androgen deficiency in women because there is neither a well-defined clinical syndrome nor reliable normative data 1. Furthermore, a blood total testosterone level should not be used to diagnose HSDD (hypogonadotropic sexual desire disorder), the only evidence-based indication for testosterone therapy 5.
2. If testosterone measurement is clinically necessary, order the correct test:
Measure total testosterone using liquid chromatography-tandem mass spectrometry (LC-MS/MS) - this is the gold standard for women 1. Standard immunoassays lack adequate sensitivity at the low concentrations found in women 1.
Then calculate free testosterone using:
- Total testosterone (by LC-MS/MS)
- SHBG level
- Albumin level
- Vermeulen's formula or similar validated calculation
Calculated free testosterone correlates excellently with equilibrium dialysis (r = 0.99) when proper assays are used 2.
3. Focus on clinical assessment, not laboratory values
If evaluating for potential androgen-related issues:
- For sexual dysfunction: Conduct full clinical assessment for hypoactive sexual desire disorder (HSDD), identifying and addressing other contributing factors (relationship issues, medications, depression, medical conditions) before considering hormonal causes 5
- For other symptoms: No evidence supports testosterone therapy for fatigue, cognitive symptoms, bone health, or muscle strength in women outside of research settings 5
Critical Pitfalls to Avoid
- Never use direct immunoassay free testosterone results for clinical decisions in women
- Never diagnose "androgen deficiency" based solely on laboratory values - this diagnosis is not validated 1
- Never prescribe testosterone therapy based on low testosterone levels alone; the only evidence-based indication is HSDD after comprehensive evaluation 5
- Avoid compounded testosterone products - they lack quality assurance and standardization 1
Bottom Line
Disregard this 0.4 pg/mL result entirely. If testosterone assessment is truly needed, repeat with total testosterone by LC-MS/MS and calculate free testosterone using validated formulas. However, recognize that even with accurate measurement, there are no established diagnostic thresholds for "androgen deficiency" in women, and treatment decisions should be based on validated clinical syndromes (primarily HSDD), not laboratory values 1, 5.